Literature DB >> 27122842

MiR-196a2 rs11614913 T>C Polymorphism is Associated with an Increased Risk of Tetralogy of Fallot in a Chinese Population.

Jian-Bing Huang1, Ju Mei1, Lian-Yong Jiang1, Zhao-Lei Jiang1, Hao Liu1, Jun-Wen Zhang1, Fang-Bao Ding1.   

Abstract

BACKGROUND: MicroRNAs (miRNAs) are a family of endogenous, small, noncoding single-stranded RNAs that act as post-transcriptional gene regulatory elements. MiRNA polymorphisms may be associated with susceptibility to congenital heart disease (CHD). The aim of this study was to evaluate the impact of miRNA single nucleotide polymorphisms (SNPs) on CHD susceptibility.
METHODS: We genotyped two functional SNPs, miR-196a2 rs11614913 and miR-146a rs2910164, in a case-control cohort of 173 Chinese patients with tetralogy of Fallot (TOF) and 207 non-CHD controls.
RESULTS: When the miR-196a2 rs11614913 TT homozygote genotype was used as the reference group, the TC genotype was not associated with an increased risk of TOF. The CC genotype was associated with a borderline significantly increased risk for TOF. In the recessive model, when the miR-196a2 rs11614913 TT/TC genotypes were used as the reference group, the CC homozygote genotype was associated with a significantly increased risk of TOF (OR = 1.96, 95% CI = 1.18-3.25, p = 0.01). The miR-146a rs2910164 C>G polymorphism was not associated with developing TOF.
CONCLUSIONS: Our findings suggested that the miR-196a2 rs11614913 T>C polymorphism may play a role in the development of TOF. Future larger studies that include populations of other ethnicities are required to confirm these findings. KEY WORDS: Congenital heart disease; MiRNA; Molecular epidemiology; Polymorphisms; Tetralogy of Fallot.

Entities:  

Year:  2015        PMID: 27122842      PMCID: PMC4804909          DOI: 10.6515/acs20140310b

Source DB:  PubMed          Journal:  Acta Cardiol Sin        ISSN: 1011-6842            Impact factor:   2.672


  20 in total

1.  MicroRNA-directed cleavage of HOXB8 mRNA.

Authors:  Soraya Yekta; I-Hung Shih; David P Bartel
Journal:  Science       Date:  2004-04-23       Impact factor: 47.728

2.  Polymorphisms of miRNAs genes are associated with the risk and prognosis of coronary artery disease.

Authors:  Hong Zhi; Lina Wang; Genshan Ma; Xingzhou Ye; Xiaojin Yu; Yi Zhu; Yu Zhang; Jiaju Zhang; Bei Wang
Journal:  Clin Res Cardiol       Date:  2011-12-11       Impact factor: 5.460

Review 3.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

Authors:  Witold Filipowicz; Suvendra N Bhattacharyya; Nahum Sonenberg
Journal:  Nat Rev Genet       Date:  2008-02       Impact factor: 53.242

Review 4.  MicroRNAs and the skin: tiny players in the body's largest organ.

Authors:  Michael Sand; Thilo Gambichler; Daniel Sand; Marina Skrygan; Peter Altmeyer; Falk G Bechara
Journal:  J Dermatol Sci       Date:  2008-12-05       Impact factor: 4.563

5.  A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma.

Authors:  Teng Xu; Ying Zhu; Qing-Kun Wei; Yunfei Yuan; Fan Zhou; Yi-Yuan Ge; Jian-Rong Yang; Hang Su; Shi-Mei Zhuang
Journal:  Carcinogenesis       Date:  2008-08-18       Impact factor: 4.944

6.  Racial and temporal variations in the prevalence of heart defects.

Authors:  L D Botto; A Correa; J D Erickson
Journal:  Pediatrics       Date:  2001-03       Impact factor: 7.124

7.  Variant allele of CHEK2 is associated with a decreased risk of esophageal cancer lymph node metastasis in a Chinese population.

Authors:  Haiyong Gu; Wanshan Qiu; Ying Wan; Guowen Ding; Weifeng Tang; Chao Liu; Yijun Shi; Yijang Chen; Suocheng Chen
Journal:  Mol Biol Rep       Date:  2011-12-27       Impact factor: 2.316

8.  The microRNA miR-196 acts upstream of Hoxb8 and Shh in limb development.

Authors:  Eran Hornstein; Jennifer H Mansfield; Soraya Yekta; Jimmy Kuang-Hsien Hu; Brian D Harfe; Michael T McManus; Scott Baskerville; David P Bartel; Clifford J Tabin
Journal:  Nature       Date:  2005-12-01       Impact factor: 49.962

Review 9.  MicroRNAs: novel regulators in cardiac development and disease.

Authors:  Thomas Thum; Daniele Catalucci; Johann Bauersachs
Journal:  Cardiovasc Res       Date:  2008-05-29       Impact factor: 10.787

10.  Methylenetetrahydrofolate reductase C677T and reduced folate carrier 80 G>A polymorphisms are associated with an increased risk of conotruncal heart defects.

Authors:  Dingxu Gong; Haiyong Gu; YuJian Zhang; Jie Gong; Yu Nie; Jue Wang; Hui Zhang; Ruiping Liu; Shengshou Hu; Hao Zhang
Journal:  Clin Chem Lab Med       Date:  2012-02-04       Impact factor: 3.694

View more
  6 in total

Review 1.  MicroRNAs in acute kidney injury.

Authors:  Pei-Chun Fan; Chia-Chun Chen; Yung-Chang Chen; Yu-Sun Chang; Pao-Hsien Chu
Journal:  Hum Genomics       Date:  2016-09-08       Impact factor: 4.639

2.  APRISMA-compliant systematic review and meta-analysis determining the association of miRNA polymorphisms and risk of congenital heart disease.

Authors:  Xing-Yan Li; Kun Chen; Zheng-Tao Lv
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

3.  Association of miR-146a and miR196a2 genotype with susceptibility to idiopathic recurrent pregnancy loss in Iranian women: A case-control study.

Authors:  Emad Babakhanzadeh; Hamid Danaei; Mohammad Abedinzadeh; Hamid Reza Ashrafzadeh; Nasrin Ghasemi
Journal:  Int J Reprod Biomed       Date:  2021-09-09

4.  Bioinformatic Analysis of the Possible Regulative Network of miR-30a/e in Cardiomyocytes 2 Days Post Myocardial Infarction.

Authors:  Yiping Wang; Yingqiong Huang; Min Zhang; Xiaoqin Zhang; Xuemei Tang; Yan Kang
Journal:  Acta Cardiol Sin       Date:  2018-03       Impact factor: 2.672

5.  Uncovering potential differentially expressed miRNAs and targeted mRNAs in myocardial infarction based on integrating analysis.

Authors:  Shiai Wang; Na Cao
Journal:  Mol Med Rep       Date:  2020-09-17       Impact factor: 2.952

Review 6.  The Role of Epigenetics in Congenital Heart Disease.

Authors:  Tingsen Benson Lim; Sik Yin Roger Foo; Ching Kit Chen
Journal:  Genes (Basel)       Date:  2021-03-09       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.